Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
HSCT in Devic's Disease
NCT00787722Phase 2Completed
- Sponsor
- Northwestern University
- Start
- Oct 2009
- Primary completion
- Nov 2018
- Modality
- Stem Cell Therapies
- Countries
- 1
01
Overview
A Phase 2 trial of autologous hematopoietic stem cells in neuromyelitis optica (NMO), sponsored by Northwestern University. Started Oct 2009; status: completed.
02
Drugs
autologous hematopoietic stem cells
03
Conditions
neuromyelitis optica (NMO)
Beyond the preview
Go deeper on NCT00787722.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT00787722.